Victory Capital Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-42,161
Closed -$1.98M 2550
2023
Q2
$1.98M Buy
42,161
+17,733
+73% +$834K ﹤0.01% 1392
2023
Q1
$1.02M Buy
24,428
+9,379
+62% +$394K ﹤0.01% 1678
2022
Q4
$574K Sell
15,049
-12,583
-46% -$480K ﹤0.01% 1961
2022
Q3
$1.08M Buy
27,632
+21,407
+344% +$838K ﹤0.01% 1700
2022
Q2
$201K Buy
+6,225
New +$201K ﹤0.01% 2354
2022
Q1
Sell
-10,928
Closed -$465K 2799
2021
Q4
$465K Buy
10,928
+1,683
+18% +$71.6K ﹤0.01% 2186
2021
Q3
$410K Buy
9,245
+2,426
+36% +$108K ﹤0.01% 2275
2021
Q2
$387K Sell
6,819
-682,185
-99% -$38.7M ﹤0.01% 2323
2021
Q1
$51.6M Sell
689,004
-44,893
-6% -$3.36M 0.05% 536
2020
Q4
$63.5M Sell
733,897
-342,840
-32% -$29.7M 0.07% 427
2020
Q3
$65.8M Buy
1,076,737
+95,631
+10% +$5.84M 0.08% 341
2020
Q2
$40.8M Sell
981,106
-1,211,610
-55% -$50.4M 0.06% 498
2020
Q1
$63M Buy
2,192,716
+1,418,129
+183% +$40.7M 0.05% 496
2019
Q4
$55.9M Buy
774,587
+191,729
+33% +$13.8M 0.07% 429
2019
Q3
$81.8M Buy
582,858
+105,967
+22% +$14.9M 0.11% 273
2019
Q2
$87.3M Buy
476,891
+42,670
+10% +$7.81M 0.18% 147
2019
Q1
$69.1M Sell
434,221
-29,320
-6% -$4.66M 0.16% 176
2018
Q4
$44.4M Buy
463,541
+42,806
+10% +$4.1M 0.11% 279
2018
Q3
$59.4M Sell
420,735
-54,930
-12% -$7.76M 0.12% 258
2018
Q2
$74.5M Buy
475,665
+40,850
+9% +$6.39M 0.16% 167
2018
Q1
$70M Buy
434,815
+152,885
+54% +$24.6M 0.15% 189
2017
Q4
$46.4M Sell
281,930
-49,475
-15% -$8.15M 0.1% 327
2017
Q3
$20.6M Sell
331,405
-114,080
-26% -$7.11M 0.05% 575
2017
Q2
$35.5M Sell
445,485
-44,930
-9% -$3.58M 0.08% 397
2017
Q1
$34.9M Buy
490,415
+16,577
+3% +$1.18M 0.08% 413
2016
Q4
$24.2M Sell
473,838
-27,720
-6% -$1.42M 0.06% 517
2016
Q3
$23.1M Buy
+501,558
New +$23.1M 0.06% 515